KR100838705B1 - 버섯 균사체 배양물, 그의 제조방법 및 그 용도 - Google Patents
버섯 균사체 배양물, 그의 제조방법 및 그 용도 Download PDFInfo
- Publication number
- KR100838705B1 KR100838705B1 KR1020070098191A KR20070098191A KR100838705B1 KR 100838705 B1 KR100838705 B1 KR 100838705B1 KR 1020070098191 A KR1020070098191 A KR 1020070098191A KR 20070098191 A KR20070098191 A KR 20070098191A KR 100838705 B1 KR100838705 B1 KR 100838705B1
- Authority
- KR
- South Korea
- Prior art keywords
- mushroom
- culture
- mycelium
- substrate
- ganoderma lucidum
- Prior art date
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 106
- 238000000034 method Methods 0.000 title claims description 13
- 238000000855 fermentation Methods 0.000 title description 5
- 230000004151 fermentation Effects 0.000 title description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 67
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 67
- 239000000758 substrate Substances 0.000 claims abstract description 25
- 239000002537 cosmetic Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000006872 improvement Effects 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 5
- 208000017520 skin disease Diseases 0.000 claims abstract description 5
- 235000021419 vinegar Nutrition 0.000 claims description 34
- 239000000052 vinegar Substances 0.000 claims description 34
- 241000411851 herbal medicine Species 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 11
- 230000003796 beauty Effects 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 241000251468 Actinopterygii Species 0.000 claims description 9
- 241000222518 Agaricus Species 0.000 claims description 4
- 230000006806 disease prevention Effects 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 3
- 238000012136 culture method Methods 0.000 claims 2
- 241001105098 Angelica keiskei Species 0.000 abstract description 8
- 240000000691 Houttuynia cordata Species 0.000 abstract description 8
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract description 8
- 235000013376 functional food Nutrition 0.000 abstract description 8
- 239000001963 growth medium Substances 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 3
- 235000001715 Lentinula edodes Nutrition 0.000 abstract description 2
- 238000012258 culturing Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241000534017 Saururus chinensis Species 0.000 abstract 3
- 241001327634 Agaricus blazei Species 0.000 abstract 1
- 244000028550 Auricularia auricula Species 0.000 abstract 1
- 235000000023 Auricularia auricula Nutrition 0.000 abstract 1
- 240000001080 Grifola frondosa Species 0.000 abstract 1
- 235000007710 Grifola frondosa Nutrition 0.000 abstract 1
- 241000414067 Inonotus obliquus Species 0.000 abstract 1
- 241000001727 Tropicoporus linteus Species 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 23
- 210000003491 skin Anatomy 0.000 description 23
- 230000000694 effects Effects 0.000 description 21
- 239000000284 extract Substances 0.000 description 18
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 18
- 239000000126 substance Substances 0.000 description 17
- 230000002401 inhibitory effect Effects 0.000 description 16
- 230000012010 growth Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 206010020751 Hypersensitivity Diseases 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 12
- 102000003425 Tyrosinase Human genes 0.000 description 11
- 108060008724 Tyrosinase Proteins 0.000 description 11
- 208000030961 allergic reaction Diseases 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 230000002087 whitening effect Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 239000000419 plant extract Substances 0.000 description 9
- 240000004160 Capsicum annuum Species 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 8
- 239000001511 capsicum annuum Substances 0.000 description 8
- 150000002989 phenols Chemical class 0.000 description 8
- 241000222336 Ganoderma Species 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 241000220317 Rosa Species 0.000 description 7
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 229920002055 compound 48/80 Polymers 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 241000245665 Taraxacum Species 0.000 description 6
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 6
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000012676 herbal extract Substances 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 208000019423 liver disease Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229940079877 pyrogallol Drugs 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 4
- 235000002567 Capsicum annuum Nutrition 0.000 description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 4
- 230000005778 DNA damage Effects 0.000 description 4
- 231100000277 DNA damage Toxicity 0.000 description 4
- 206010012438 Dermatitis atopic Diseases 0.000 description 4
- 240000008881 Oenanthe javanica Species 0.000 description 4
- 235000000365 Oenanthe javanica Nutrition 0.000 description 4
- 244000050053 Rosa multiflora Species 0.000 description 4
- 235000000656 Rosa multiflora Nutrition 0.000 description 4
- 241000722281 Saururus Species 0.000 description 4
- 241000292546 Taraxacum mongolicum Species 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 201000008937 atopic dermatitis Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229950001002 cianidanol Drugs 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 229960003699 evans blue Drugs 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000004789 Rosa xanthina Nutrition 0.000 description 3
- 241000109329 Rosa xanthina Species 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 240000008932 Sison amomum Species 0.000 description 3
- 235000011192 Sison amomum Nutrition 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000003416 augmentation Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 238000012364 cultivation method Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000001965 potato dextrose agar Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical compound OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010058679 Skin oedema Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 210000000885 nephron Anatomy 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018999 Haemorrhage subcutaneous Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 101000741967 Homo sapiens Presequence protease, mitochondrial Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000208317 Petroselinum Species 0.000 description 1
- 102100038632 Presequence protease, mitochondrial Human genes 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010216 atopic IgE responsiveness Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- -1 hydroxy stilbenamide Chemical compound 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 235000021264 seasoned food Nutrition 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
성분 | 배지 a) | ||||||||
MYPA | PDA | ME | YM | YMPG | MCM | PYG | GP | GPY | |
Potato | 250.0 | ||||||||
K2HPO4 | 1.0 | 10 | |||||||
KH2PO4 | 2.0 | 0.46 | |||||||
MgSO47H2O | 1.0 | 0.5 | 0.7 | 0.5 | |||||
FeSO47H2O | |||||||||
Glucose | 20.0 | 10.0 | 10.0 | 20.0 | 14 | 30 | 20 | ||
Thiamine-HCl | 1.0b) | ||||||||
DL-Asparagine | 1.0 | ||||||||
Peptone | 1.0 | 5.0 | 5.0 | 2.0 | 2.0 | 1.25 | 3 | 2 | |
Malt extract | 30.0 | 20.0 | 3.0 | 10.0 | |||||
Yeast extract | 2.0 | 3.0 | 2.0 | 2.0 | 1.25 | 2 | |||
Agar | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 |
시료 | 총페놀 화함물의 양(㎍/mL) | ||
100 | 500 | 1000 | |
Houttuynia Cordata | 12 | 52 | 100 |
Saururus Chinesis(Lour) Bail | 17 | 84 | 156 |
Oenanthe javanica | 15 | 76 | 136 |
Rosa multiflora | 72 | 313 | 585 |
Taraxacum mongolicum | 16 | 72 | 145 |
Capsicum annuum | 3 | 20 | 57 |
Angelica keiskei | 12 | 30 | 72 |
HS Fermentation | 8 | 45 | 88 |
시료 | EDA(%) | ||
100 | 500 | 1,000 (㎍/mL) | |
vitamin E(Tocopherol) | 18.8 | 92.5 | 92.8 |
Chlorogenic acid | 45.7 | 92.4 | 93.5 |
BHA | 82.2 | 86.7 | 87.8 |
ascorbic acid | 87.2 | 95.1 | 95.2 |
catechin | 85.5 | 87.1 | 87.3 |
Houttuynia Cordata | 45.2 | 85.6 | 87.3 |
Saururus Chinesis(Lour) Bail | 72.9 | 78.3 | 85.7 |
Oenanthe javanica | 15.49 | 65.30 | 88.69 |
Rosa multiflora | 90.76 | 92.70 | 92.78 |
Taraxacum mongolicum | 15.02 | 64.08 | 89.89 |
Capsicum annuum | 5.87 | 13.08 | 27.66 |
Angelica keiskei | 7.48 | 27.84 | 57.06 |
HS Fermentation | 68.5 | 87.3 | 90.3 |
시료 | 억제(%) | ||
100 | 500 | 1,000(㎍/㎖) | |
BHA | 6.45 | 4.86 | 42.5 |
ascorbic acid | 10.00 | 28.56 | 63.11 |
catechin | 7.76 | 5.07 | 3.96 |
Houttuynia Cordata | 5.85 | - | - |
Saururus Chinesis(Lour) Bail | 10.27 | 11.44 | 6.37 |
Oenanthe javanica | 0.64 | 18.96 | 13.71 |
Rosa multiflora | - | 12.65 | 9.35 |
Taraxacum mongolicum | 0.64 | 17.16 | 13.41 |
Capsicum annuum | 3.27 | 19.64 | 15.28 |
Angelica keiskei | 2.37 | 19.80 | 13.33 |
HS Fermentation | 11.5 | 10.45 | 8.66 |
시료 | 저해율(%) | ||
100 | 500 | 1,000 (㎍/mL) | |
BHA | 4.3 | - | 28.59 |
ascorbic acid | 20.01 | 98.75 | 99.80 |
catechin | 32.51 | - | - |
Houttuynia cordata | - | - | 2.43 |
Saururus chinesis(Lour) Bail | 9.08 | - | - |
Oenanthe javanica | 11.5 | 13.38 | 8.82 |
Rosa multiflora | 10.21 | 32.23 | 33.39 |
Taraxacum mongolicum | 10.61 | 14.70 | 9.34 |
Capsicum annuum | 13.25 | 14.48 | - |
Angelica keiskei | 13.06 | 13.03 | 9.45 |
HS Fermentation | 10.56 | - | - |
Claims (16)
- 신선초, 어성초 및 삼백초로 구성된 생약초를 기질로 한 배지에 종균으로 버섯 균사체를 접종하여 배양한 버섯 균사체 배양물.
- 제 1항에 있어서, 상기 기질이 신선초 100 중량부에 대하여 어성초와 삼백초를 25~75% : 75~25% (w:w)로 혼합한 혼합 생약초 30~50 중량부를 포함하는 것을 특징으로 하는 버섯 균사체 배양물.
- 제 1항에 있어서, 상기 버섯이 영지버섯, 상황버섯, 표고버섯, 아가리쿠스 버섯, 차가버섯, 목이버섯, 송이버섯 및 잎새버섯으로 이루어진 군에서 선택된 1종 이상인 것을 특징으로 하는 버섯 균사체 배양물.
- 제 1항에 있어서, 상기 배지의 수분함량이 상기 기질의 중량에 대하여 1.5~2.5배 (w/w)인 것을 특징으로 하는 버섯 균사체 배양물.
- 제 1항에 있어서, 상기 버섯 균사체의 접종량이 3~7% (v/w)인 것을 특징으로 하는 버섯 균사체 배양물.
- 제 1항에 있어서, 상기 배양조건이 25~32℃의 온도 및 pH 5.0~6.0의 조건에 서 30~40일간 배양하는 것을 특징으로 하는 버섯 균사체 배양물.
- (a). 신선초 100 중량부에 대하여 어성초와 삼백초를 25~75% : 75~25% (w:w)로 혼합한 혼합 생약초 30~50 중량부를 혼합하여 버섯 균사체의 기질을 조제하는 단계; 및(b). 상기 조제된 기질에 종균으로 버섯 균사체를 접종하여 배양하는 단계; 를 포함하는 것을 특징으로 하는 버섯 균사체 배양물의 제조방법.
- 제 7항에 있어서, 상기 버섯이 영지버섯, 상황버섯, 표고버섯, 아가리쿠스 버섯, 차가버섯, 목이버섯, 송이버섯 및 잎새버섯으로 이루어진 군에서 선택된 1종 이상인 것을 특징으로 하는 버섯 균사체 배양물의 제조방법.
- 제 7항에 있어서, 상기 (b)단계에서 배지의 수분함량을 상기 기질의 중량에 대하여 1.5~2.5배 (w/w)로 조절하는 것을 특징으로 하는 버섯 균사체 배양물의 제조방법.
- 제 7항에 있어서, 상기 배양조건이 25~32℃의 온도 및 pH 5.0~6.0의 조건에서 30~40일간 배양하는 것을 특징으로 하는 버섯 균사체 배양물의 제조방법.
- 제 1항 내지 제 6항 중 어느 하나의 항에 의한 버섯 균사체 배양물을 유효성분으로 함유하는 피부개선 또는 피부질환 예방용 미용건강 식품.
- 삭제
- 제 11항에 있어서, 상기 식품이 음료인 것을 특징으로 하는 미용건강 식품.
- 삭제
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070098191A KR100838705B1 (ko) | 2007-09-28 | 2007-09-28 | 버섯 균사체 배양물, 그의 제조방법 및 그 용도 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070098191A KR100838705B1 (ko) | 2007-09-28 | 2007-09-28 | 버섯 균사체 배양물, 그의 제조방법 및 그 용도 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080024410A Division KR100848515B1 (ko) | 2008-03-17 | 2008-03-17 | 버섯 균사체 배양물을 유효성분으로 함유하는 미백화장품 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100838705B1 true KR100838705B1 (ko) | 2008-06-16 |
Family
ID=39771533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070098191A KR100838705B1 (ko) | 2007-09-28 | 2007-09-28 | 버섯 균사체 배양물, 그의 제조방법 및 그 용도 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100838705B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101075006B1 (ko) * | 2009-01-21 | 2011-10-20 | 권상철 | 아토피 피부염 예방 및 치료용 조성물 |
KR101366472B1 (ko) * | 2012-01-12 | 2014-02-24 | 계명대학교 산학협력단 | 꽃송이 버섯 균사체 배양액을 포함하는 천연항균제, 이를 포함하는 식품, 화장료 또는 사료 조성물 |
KR20210123806A (ko) * | 2020-04-06 | 2021-10-14 | 박종례 | 버섯 복합배양 균사체, 싱아, 바위솔 및 비름의 혼합 추출물을 함유하는 항알레르기성 조성물 |
CN115380764A (zh) * | 2021-10-13 | 2022-11-25 | 江西农业大学 | 一株野生脆木耳菌及其脆木耳的驯化栽培方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050079702A (ko) * | 2004-02-06 | 2005-08-11 | 주식회사 황토생활건강 | 황토 함유 미용 조성물 |
KR20070036224A (ko) * | 2005-09-29 | 2007-04-03 | 에스피엘메디코스(주) | 복합 생약 추출물을 함유하는 화장료 조성물 |
-
2007
- 2007-09-28 KR KR1020070098191A patent/KR100838705B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050079702A (ko) * | 2004-02-06 | 2005-08-11 | 주식회사 황토생활건강 | 황토 함유 미용 조성물 |
KR20070036224A (ko) * | 2005-09-29 | 2007-04-03 | 에스피엘메디코스(주) | 복합 생약 추출물을 함유하는 화장료 조성물 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101075006B1 (ko) * | 2009-01-21 | 2011-10-20 | 권상철 | 아토피 피부염 예방 및 치료용 조성물 |
KR101366472B1 (ko) * | 2012-01-12 | 2014-02-24 | 계명대학교 산학협력단 | 꽃송이 버섯 균사체 배양액을 포함하는 천연항균제, 이를 포함하는 식품, 화장료 또는 사료 조성물 |
KR20210123806A (ko) * | 2020-04-06 | 2021-10-14 | 박종례 | 버섯 복합배양 균사체, 싱아, 바위솔 및 비름의 혼합 추출물을 함유하는 항알레르기성 조성물 |
KR102357614B1 (ko) * | 2020-04-06 | 2022-01-28 | 박종례 | 버섯 복합배양 균사체, 싱아, 바위솔 및 비름의 혼합 추출물을 함유하는 항알레르기성 조성물 |
CN115380764A (zh) * | 2021-10-13 | 2022-11-25 | 江西农业大学 | 一株野生脆木耳菌及其脆木耳的驯化栽培方法 |
CN115380764B (zh) * | 2021-10-13 | 2024-05-14 | 江西农业大学 | 一株脆木耳菌及其脆木耳的驯化栽培方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9394513B2 (en) | Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant | |
KR100848515B1 (ko) | 버섯 균사체 배양물을 유효성분으로 함유하는 미백화장품 | |
KR100962587B1 (ko) | 천연 식물소재 및 한약재의 발효방법, 상기 방법에 의해서제조된 발효물 및 이를 함유하는 약학 조성물, 화장품조성물 및 식품 조성물 | |
KR101456061B1 (ko) | 피부트러블 완화용 화장료 조성물 | |
KR100988072B1 (ko) | 황칠나무 발효물 및 그것을 포함하는 약학 조성물 | |
KR20120107557A (ko) | 엽록소가 함유된 미강의 발효추출물 및 그 제조방법 | |
KR20090123458A (ko) | 천연 식물소재 또는 한약재의 발효방법, 상기 방법에의해서 제조된 발효물 및 이를 함유하는 화장료 조성물,식료품 조성물 및 약학 조성물 | |
KR101456062B1 (ko) | 피부트러블 완화용 화장료 조성물 | |
KR20090002677A (ko) | 항산화 활성을 갖는 화장료 조성물 | |
WO2011019239A2 (ko) | 천연 추출물 함유 조성물 | |
KR101456044B1 (ko) | 피부트러블 완화용 화장료 조성물 | |
GB2341800A (en) | Activating antitumour polysaccharide drugs | |
KR100838705B1 (ko) | 버섯 균사체 배양물, 그의 제조방법 및 그 용도 | |
KR101078933B1 (ko) | 락토바실러스 속의 젖산균으로 발효된 버섯 발효 추출물 및 이를 함유하는 조성물 | |
KR101219650B1 (ko) | 옻의 무독화 방법 및 무독화 옻피 추출물의 용도 | |
KR102174660B1 (ko) | 천연식물 발효액 및 천연식물 분말을 포함하는 화장품 조성물 및 이의 제조방법 | |
KR102139732B1 (ko) | 유산균을 함유하는 면역 기능 개선용 조성물 | |
KR102254420B1 (ko) | 약용 및 식용 천연물 복합 발효액을 유효성분으로 함유하는 항균 조성물 | |
KR102507651B1 (ko) | 전통주 효모 함유 천연발효효소복합액을 이용한 숙취해소, 알콜성간질환 또는 간기능 개선용 멀꿀발효물과 그 제조방법 | |
KR100697655B1 (ko) | 미생물 발효에 의해 안전성이 증진된 발효 구아바 조성물 | |
KR20230138679A (ko) | 홍경천 발효물을 포함하는 인지기능 장애 또는 기억력 장애 예방 또는 개선용 조성물 | |
KR101652930B1 (ko) | 사카로마이세스 세레비지애를 이용한 은행 외과피의 혐오취 저감 방법 | |
KR20140084502A (ko) | 알로에와 울금을 이용한 혼합발효물을 유효성분으로 하는 간 기능 개선용 조성물과 그 제조방법 및 이를 이용한 간 기능 개선용 제제 | |
KR20120132646A (ko) | 항산화 및 면역기능 증진효과가 우수한 상황버섯 균사체 배양 방법 | |
KR102686642B1 (ko) | 알로에 노루궁뎅이버섯 균사체 발효물 함유 분말의 제조방법 및 이에 따라 제조된 분말을 포함하는 기능성 식품 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130531 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140523 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150512 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160428 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170517 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190610 Year of fee payment: 12 |